PSIAC
Sad Pill Bild Bildrechte: © spinetta / Fotolia

Oops!

Sie verwenden eine veraltete Version Ihres Internetbrowsers und können nicht auf die Inhalte der Seite zugreifen.
Bitte aktualisieren Sie Ihre Browserversion.

PSIAC

Literaturverzeichnis

Erweiterte Suche
Custodio J, West S, Vu A, et al., Pharmacokinetics of bictegravir administered twice daily with rifampin. Paper presented at: The Conference on Retroviruses and Opportunistic Infections (CROI); 2018; Boston, MA. Available from: http://www.croiconference.org/sessions/ pharmacokinetics-bictegravir-administered-twice-daily-combinationrifampin. Accessed May 29, 2018. [7490]
Custodio J, West S, Vu A, et al., Pharmacokinetics of bictegravir administered twice daily with rifampin. Paper presented at: The Conference on Retroviruses and Opportunistic Infections (CROI); 2018; Boston, MA. Available from: http://www.croiconference.org/sessions/ pharmacokinetics-bictegravir-administered-twice-daily-combinationrifampin. Accessed May 29, 2018.. [7486]
Custodio J, West S, Vu A, et al., Pharmacokinetics of bictegravir administered twice daily with rifampin. Paper presented at: The Conference on Retroviruses and Opportunistic Infections (CROI); 2018; Boston, MA. Available from: http://www.croiconference.org/sessions/ pharmacokinetics-bictegravir-administered-twice-daily-combinationrifampin. Accessed May 29, 2018.. [7487]
Custodio JM. J Clin Pharmacol. Jun 2014; 54(6): 649-56 Pubmed [6670]
Custodio JM. Pharmacol Res Perspect. Oct 2017; 5(5) Pubmed, Volltext, DOI [7437]
Custodio, West S, Vu A, et al., Pharmacokinetics of bictegravir administered twice daily with rifampin. Paper presented at: The Conference on Retroviruses and Opportunistic Infections (CROI); 2018; Boston, MA. Available from: http://www.croiconference.org/sessions/ pharmacokinetics-bictegravir-administered-twice-daily-combinationrifampin. Accessed May 29, 2018.. [7483]
Custodio, West S, Vu A, et al., Pharmacokinetics of bictegravir administered twice daily with rifampin. Paper presented at: The Conference on Retroviruses and Opportunistic Infections (CROI); 2018; Boston, MA. Available from: http://www.croiconference.org/sessions/ pharmacokinetics-bictegravir-administered-twice-daily-combinationrifampin. Accessed May 29, 2018.. [7484]
Custodio, West S, Vu A, et al., Pharmacokinetics of bictegravir administered twice daily with rifampin. Paper presented at: The Conference on Retroviruses and Opportunistic Infections (CROI); 2018; Boston, MA. Available from: http://www.croiconference.org/sessions/ pharmacokinetics-bictegravir-administered-twice-daily-combinationrifampin. Accessed May 29, 2018.. [7485]
Cuthbert MF. Br J Pharmacol. Oct 1971; 43(2): 471P-472P Pubmed, Volltext [2360]
Cutler AJ. CNS Spectr. Feb 2018; 23(1): 39-50 Pubmed [4906]
Cutler NR. Prog Neuropsychopharmacol Biol Psychiatry. Jan 1984; 8(2): 277-83 Pubmed [1428]
Cuzzolin L. Expert Opin Drug Metab Toxicol. Aug 2018; 14(8): 855-868 Pubmed [7824]
Cvetkovic RS. Drugs. Jan 2003; 63(8): 769-802 Pubmed [5850]
Cymbalta®,Fachinformation, Stand der Information Dez. 2012 [3594]
Cysneiros RM. Clin Pharmacol Ther. Jul 2007; 82(1): 54-62 Pubmed [2507]
Czuczwar M. Pol J Pharmacol. Sep 2003; 55(5): 799-802 Pubmed [759]
Czuczwar SJ. Expert Opin Drug Metab Toxicol. Feb 2009; 5(2): 131-6 Pubmed [9278]
Czyrak A. Arzneimittelforschung. Feb 1994; 44(2): 113-8 Pubmed [11064]
D. Schmidt, G. Eckermann, U. Fuhr, G. Luef, B.J. Steinhoff, C.E.Elger, Arzneimittelinteraktionen bei der medikamentösen Epilepsietherapie: ein kritischer Überblick, Nervenheilkunde (Nov. 2007) [2766]
D. Schmidt, G. Eckermann, U. Fuhr, G. Luef, B.J. Steinhoff, C.E.Elger. Nervenheilkunde 2007; 26(11): 969-980. Nov 2007; 26(11): 969-980 Pubmed [12553]
D. Schmidt, G. Eckermann, U. Fuhr, G. Luef, B.J. Steinhoff, C.E.Elger. Nervenheilkunde 2007; 26(11): 969-980. Nov 2007; 26(11): 969-980. Nov 0207; 26(11): 969-980 Pubmed [12554]
D'Arrigo C. Pharmacol Res. Dec 2005; 52(6): 497-501 Pubmed [2687]
D'Cunha R. Biopharm Drug Dispos. Oct 2016; 37(7): 397-408 Pubmed [7615]
D'Elia C. Urol Int. Oct 2019; : 1-6 Pubmed [8118]
D'Emanuele A. Adv Drug Deliv Rev. Dec 2005; 57(15): 2147-62 Pubmed [13033]
D'Onofrio F. Neurol Sci. May 2017; 38(Suppl 1): 117-120 Pubmed [11550]
Da Rocha et al. (2008) Rev Bras Psiquiatr 30:400-401 [2881]
Daali Y. Metabolism. Nov 2011; 60(11): 1584-9 Pubmed [8180]
Daar ES. Lancet HIV. Jul 2018; 5(7): e347-e356 Pubmed [7637]
Dabbert D. Reactions weekly. Jul 2012; 1411(9) Pubmed [11927]
Dabbous IA. J Pediatr. Apr 1970; 76(4): 617-20 Pubmed [9290]
Dactinomycin. Stand Jul 2022. https://www.fachinfo.de/api/fachinfo/pdf/020690 [12322]
Dahlin MG. Pediatr Neurol. Oct 2010; 43(4): 231-5 Pubmed [9520]
Dahlinger D. Ther Adv Urol. Jun 2017; 9(7): 163-177 Pubmed, Volltext, DOI [10211]
Dai CL. Biochem Pharmacol. Aug 2009; 78(4): 355-64 Pubmed, Volltext, DOI [4587]
Dai CX. Medicine (Baltimore). Sep 2018; 97(39): e12421 Pubmed [11858]
Dai H. J Pharmacol Exp Ther. Mar 2003; 304(3): 1085-92 Pubmed [4984]
Dai J. Cancer Med. Mar 2021; 10(5): 1738-1744 Pubmed [12962]
Dai LL. Xenobiotica. Oct 2013; 43(10): 862-7 Pubmed [3466]
Dal Verme A. Medicina (B Aires). Jan 2012; 72(6): 475-7 Pubmed [6443]
Dalén P. Pharmacogenetics. Oct 1996; 6(5): 387-94 Pubmed [283]
Dall M. Clin Gastroenterol Hepatol. Dec 2009; 7(12): 1314-21 Pubmed [994]
Dalle JH. Arch Pediatr. Oct 2001; 8(10): 1078-81 Pubmed [5347]
Dalle JH. J Pediatr Hematol Oncol. May 2002; 24(4): 321-2 Pubmed [5346]
Dallocchio C. J Clin Neurosci. May 2002; 9(3): 310-1 Pubmed [3395]
Dalmadi B. Drug Metab Dispos. May 2003; 31(5): 631-6 Pubmed [4016]
Dalton MJ. Drug Intell Clin Pharm. Dec 1985; 19(12): 941-4 Pubmed [769]
Daly EJ. JAMA Psychiatry. Sep 2019; 76(9): 893-903 Pubmed [12067]
Daly. JAMA. Pubmed [12065]
Dalziel SR. Lancet. May 2019; 393(10186): 2135-2145 Pubmed [10619]
Damkier P. Basic Clin Pharmacol Toxicol. Jan 2019; 124(1): 28-31 Pubmed [13602]
Damkier P. Br J Clin Pharmacol. Dec 1999; 48(6): 829-38 Pubmed, Volltext, DOI [4007]
Damkier P. Pharmacol Toxicol. Dec 1999; 85(6): 257-62 Pubmed [6105]
Damle B. Antimicrob Agents Chemother. Nov 2011; 55(11): 5172-7 Pubmed, Volltext, DOI [5938]
Damle B. Antimicrob Agents Chemother. Sep 2011; 55(9): 4302-7 Pubmed, Volltext, DOI [7611]
Damle B. Br J Clin Pharmacol. Apr 2008; 65(4): 523-30 Pubmed, Volltext, DOI [6333]
Damle B. J Clin Pharmacol. Mar 2009; 49(3): 291-300 Pubmed [11379]
Damle BD. Antimicrob Agents Chemother. Feb 2002; 46(2): 385-91 Pubmed, Volltext, DOI [6908]
Dams et al. J Anal Toxicol (2001) 25: 716-717 [988]
Damy T. Fundam Clin Pharmacol. Feb 2004; 18(1): 113-23 Pubmed [3720]
Dan Y. J Pharm Pharmacol. May 2002; 54(5): 729-33 Pubmed [4575]
Danaher PJ. Orthopedics. Jun 2009; 32(6): 450 Pubmed [6459]
Danek PJ. Pharmacol Rep. Dec 2020; 72(6): 1685-1694 Pubmed [11476]
Danek PJ. Toxicol Appl Pharmacol. Nov 2020; 406: 115239 Pubmed [11477]
Daneshmend, Roberts. Brit J Clin Pharmacol (1982) 14, 73-78 [1342]
Dang W. Antimicrob Agents Chemother. Oct 2018; 62(11) Pubmed, Volltext, DOI [8626]
Daniel DG. Am J Psychiatry. May 1996; 153(5): 734 Pubmed [1379]
Daniel et al. J Clin Psychopharmacol (1994) 14, 340-343 [1476]
Danielak D. Eur J Pharm Sci. Jul 2022; 176: 106254 Pubmed [12400]
Daniele C. Drug Saf. Jan 2005; 28(4): 319-32 Pubmed [13640]
Daniell HW. J Opioid Manag. Mar 2011; 7(2): 155-9 Pubmed [9585]
Daniels NJ. Lancet. Sep 1984; 2(8403): 639 Pubmed [6206]
Danielsson B. BMJ Open. Mar 2020; 10(3): e034560 Pubmed, Volltext, DOI [9285]
Danielsson B. Br J Clin Pharmacol. Apr 2016; 81(4): 773-83 Pubmed, Volltext, DOI [8868]
Dannawi M. J Psychopharmacol. Dec 2002; 16(4): 401 Pubmed [2800]
Dansette PM. Chem Res Toxicol. Jul 2010; 23(7): 1268-74 Pubmed [3290]
Dantoine T. Int J Clin Pract. Jan 2006; 60(1): 110-8 Pubmed [9932]
Dar H. JAMA Netw Open. Jun 2021; 4(6): e2114904 Pubmed [10946]
Dardennes RM. Prog Neuropsychopharmacol Biol Psychiatry. May 2010; 34(4): 724-5 Pubmed [1090]
Dardis C. Neurologist. Jul 2012; 18(4): 204-5 Pubmed [10680]
Darley J. Seizure. Jun 1994; 3(2): 151-2 Pubmed [1375]
Darvari R. J Pharm Pharmacol. Aug 2004; 56(8): 985-91 Pubmed [10191]
Darwish M. Clin Pharmacokinet. Jan 2008; 47(1): 61-74 Pubmed [306]
Darwish M. Pharmacopsychiatry. Jul 2015; 48(4-5): 170-5 Pubmed [4134]
Darwish. J Am Geriatr Soc (1999) 47, S62 [1297]
Das S. Pharmacol Res Perspect. Oct 2015; 3(5): e00172 Pubmed, Volltext, DOI [5177]
Dastjerdi MS. Int J Obes (Lond). Apr 2007; 31(4): 713-7 Pubmed [1362]
Datta A. Cureus. Sep 2021; 13(9): e18032 Pubmed [13275]
Datta A. Pain Manag. Jul 2022; 12(5): 587-594 Pubmed [13503]
Dattani RG. Eur J Clin Pharmacol. Nov 2004; 60(9): 679-82 Pubmed [11364]
Dattilo PB. J Clin Psychiatry. Aug 2007; 68(8): 1309-10 Pubmed [3406]
Dauri M. Clin Drug Investig. May 2014; 34(5): 309-16 Pubmed [9469]
Davey PG. J Antimicrob Chemother. Sep 1988; 22 Suppl C: 97-107 Pubmed [5294]
David M. Therapie. Jan 1998; 53(1): 78-80 Pubmed [8240]
David OJ. Clin Pharmacokinet. Jan 2012; 51(1): 15-28 Pubmed [10037]
David OJ. Clin Pharmacol Drug Dev. Aug 2018; 7(6): 575-586 Pubmed, Volltext, DOI [10041]
David OJ. Int J Clin Pharmacol Ther. Aug 2012; 50(8): 540-4 Pubmed [10073]
Davidge Pitts CJ. Mayo Clin Proc. Apr 2011; 86(4): 338-43; quiz 343 Pubmed, Volltext, DOI [3715]
Davids E. J Clin Psychopharmacol. Apr 2000; 20(2): 270-1 Pubmed [8499]
Davids E. Prog Neuropsychopharmacol Biol Psychiatry. Aug 2006; 30(6): 1033-8 Pubmed [11706]